---
layout: post
title: New Drug Approvals - Pt. IX - Besifloxacin (Besivance)
date: '2009-07-06T16:13:00.019+01:00'
author: Patricia
tags:
- 2009 New Drugs
modified_time: '2009-08-18T14:21:43.401+01:00'
thumbnail: http://3.bp.blogspot.com/_GrFxGiayAGE/SlIdVBGSRuI/AAAAAAAAANE/naH70Q8slEs/s72-c/Besivance.jpg
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-5257650221799276237
blogger_orig_url: http://chembl.blogspot.com/2009/07/new-drug-approvals-pt-ix-besifloxacin.html
---

<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_GrFxGiayAGE/SlIdVBGSRuI/AAAAAAAAANE/naH70Q8slEs/s1600-h/Besivance.jpg"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 126px; height: 200px;" src="http://3.bp.blogspot.com/_GrFxGiayAGE/SlIdVBGSRuI/AAAAAAAAANE/naH70Q8slEs/s200/Besivance.jpg" alt="" id="BLOGGER_PHOTO_ID_5355375153806198498" border="0" /></a>
<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_GrFxGiayAGE/SoqqlaGUxTI/AAAAAAAAASU/7lmTHtGSBo4/s1600-h/Besifloxacin_newIcons.png"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 37px;" src="http://2.bp.blogspot.com/_GrFxGiayAGE/SoqqlaGUxTI/AAAAAAAAASU/7lmTHtGSBo4/s320/Besifloxacin_newIcons.png" alt="" id="BLOGGER_PHOTO_ID_5371293065230468402" border="0" /></a><p>
Also on the market this year is Besifloxacin Hydrochloride (USAN) which is marketed as Besivance, approved on May 28th. Besifloxacin is a fluoroquinolone antimicrobial indicated for the treatment of bacterial conjunctivitis, and competes against other fluoroquinolones for the ophthalmic treatment of bacterial infections. Besifloxacin has activity against <a href="http://en.wikipedia.org/wiki/Gram_positive">Gram-positive</a> and <a href="http://en.wikipedia.org/wiki/Gram_negative">Gram-negative</a> bacteria and acts through inhibition of both bacterial DNA gyrase and topoisomerase IV. Besifloxacin is known to be active against various <a href="http://en.wikipedia.org/wiki/Corynebacterium">Corynebacterium</a>, <a href="http://en.wikipedia.org/wiki/Haemophilus">Haemophilus</a>, <a href="http://en.wikipedia.org/wiki/Moraxella">Moraxella</a>, <a href="http://en.wikipedia.org/wiki/Staphylococcus">Staphylococcus</a> and <a href="http://en.wikipedia.org/wiki/Streptococcus">Streptococcus</a> <i>spp.</i> Besifloxacin is a small molecule drug (Molecular Weight of 393.8 g.mol-1 for Besifloxacin itself, and 430.3 g.mol-1 for the HCl salt), is Rule-of-Five compliant and is delivered as an ophthalmic suspension. Besifloxacin has a plasma half-life is of 7 hours. Recommended dosage is one drop instilled in the affected eye(s) 3 times a day, four to twelve hours apart, for 7 days. The full prescribing information is <a href="http://www.besivance.com/Besivance-Full-Prescribing-Info.pdf">here</a>.
</p><p>
The structure (+)-7[(3R)-3-aminohexahydro-1H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) contains both an amine and a carboxylic acid functional group, and so will normally exist as a <a href="http://en.wikipedia.org/wiki/Zwitterion">zwitterion</a>. Overall, Besifloxacin is a rigid molecule with few rotatable bonds. The fluoroquinolone class of antibiotics is quite extensive, and is named after the fluro-substituted, fused six-six ring structure at the center of the molecule containing a nitrogen and also the aryl-ketone (the 'one' part of the name).
</p><p>
<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_GrFxGiayAGE/SlIarvFvnzI/AAAAAAAAAM0/EsnkOpZ8dB0/s1600-h/Besifloxacin.png"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 195px; height: 146px;" src="http://2.bp.blogspot.com/_GrFxGiayAGE/SlIarvFvnzI/AAAAAAAAAM0/EsnkOpZ8dB0/s320/Besifloxacin.png" alt="" id="BLOGGER_PHOTO_ID_5355372245574197042" border="0" /></a>
</p><p>
Besifloxacin Canonical SMILES: N[C@@H]4CCCCN(c3c(F)cc2c(=O)c(C(=O)O)cn(C1CC1)c2c3Cl)C4

Besifloxacin InChI: <span id="inchi">InChI=1S/C19H21ClFN3O3/c20-15-16-12(18(25)13(19(26)27)9-24(16)11-4-5-11)7-14(21)17(15)23-6-2-1-3-10(22)8-23/h7,9-11H,1-6,8,22H2,(H,26,27)</span>

Besifloxacin InChIKey: <span id="inchikey">QFFGVLORLPOAEC-UHFFFAOYSA-N</span>

Besifloxacin CAS registry: 141388-76-3

Besifloxacin ChemDraw: <a href="http://www.ebi.ac.uk/chembl/downloads/Besifloxacin.cdx">Besifloxacin.cdx</a>
</p><p>
The manufacturer of Besifloxacin is <a href="http://www.bausch.com/">Bausch &amp; Lomb, Inc.</a> and the product website is <a href="http://www.besivance.com/">www.besivance.com</a>.</p>